WO2010018438A3 - Tetrazole glycosides - Google Patents
Tetrazole glycosides Download PDFInfo
- Publication number
- WO2010018438A3 WO2010018438A3 PCT/IB2009/006497 IB2009006497W WO2010018438A3 WO 2010018438 A3 WO2010018438 A3 WO 2010018438A3 IB 2009006497 W IB2009006497 W IB 2009006497W WO 2010018438 A3 WO2010018438 A3 WO 2010018438A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tetrazole
- glycosides
- sglt2
- sglt
- transporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the tetrazole glycosides derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1934/CHE/2008 | 2008-08-11 | ||
| IN1934CH2008 | 2008-08-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010018438A2 WO2010018438A2 (en) | 2010-02-18 |
| WO2010018438A3 true WO2010018438A3 (en) | 2011-01-20 |
Family
ID=41669393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2009/006497 Ceased WO2010018438A2 (en) | 2008-08-11 | 2009-08-05 | Tetrazole glycosides |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2010018438A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108358863A (en) * | 2018-03-08 | 2018-08-03 | 湖北佰智昂生物化工有限公司 | A kind of method that zinc lewis acid Surfactant-Catalyzed prepares 5 '-substituted tetrazole compounds |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221865B1 (en) * | 1995-11-06 | 2001-04-24 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
| WO2004073594A2 (en) * | 2003-02-12 | 2004-09-02 | L'oreal | Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or skin appendages |
| WO2004099230A1 (en) * | 2003-05-12 | 2004-11-18 | Fujisawa Pharmaceutical Co., Ltd. | Monosaccharide compounds |
| WO2004106293A2 (en) * | 2003-05-21 | 2004-12-09 | Bristol-Myers Squibb Company | Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| WO2005021566A2 (en) * | 2003-08-26 | 2005-03-10 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy- pirazoles, drugs containing said compounds the use and production method thereof |
| EP1637539A1 (en) * | 2003-06-20 | 2006-03-22 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| WO2006033001A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Quinoline compounds |
-
2009
- 2009-08-05 WO PCT/IB2009/006497 patent/WO2010018438A2/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221865B1 (en) * | 1995-11-06 | 2001-04-24 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
| WO2004073594A2 (en) * | 2003-02-12 | 2004-09-02 | L'oreal | Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or skin appendages |
| WO2004099230A1 (en) * | 2003-05-12 | 2004-11-18 | Fujisawa Pharmaceutical Co., Ltd. | Monosaccharide compounds |
| WO2004106293A2 (en) * | 2003-05-21 | 2004-12-09 | Bristol-Myers Squibb Company | Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| EP1637539A1 (en) * | 2003-06-20 | 2006-03-22 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| WO2005021566A2 (en) * | 2003-08-26 | 2005-03-10 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy- pirazoles, drugs containing said compounds the use and production method thereof |
| WO2006033001A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Quinoline compounds |
Non-Patent Citations (3)
| Title |
|---|
| ANDREINI, F. ET AL: "Modification of the 1,2,3-triazole ring present in an effective in vitro inhibitor of prostaglandin synthesis", FARMACO , 44(9), 831 -41 CODEN: FRMCE8; ISSN: 0014-827X, 1989, XP002610493 * |
| HUISGEN, ROLF ET AL: "Ring opening of azoles. II. The formation of 1,3,4-oxadiazoles in the acylation of 5-substituted tetrazoles", CHEMISCHE BERICHTE , 93, 2106 -24 CODEN: CHBEAM; ISSN: 0009-2940, 1960, XP002610492 * |
| JEFFERSON W TILLEY ET AL: "Carboxylic Acids and Tetrazoles as Isosteric Replacements for Sulfate in Cholecystokinin Analogues", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 34, no. 3, 1 March 1991 (1991-03-01), pages 1125 - 1136, XP002413472, ISSN: 0022-2623, DOI: DOI:10.1021/JM00107A037 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108358863A (en) * | 2018-03-08 | 2018-08-03 | 湖北佰智昂生物化工有限公司 | A kind of method that zinc lewis acid Surfactant-Catalyzed prepares 5 '-substituted tetrazole compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010018438A2 (en) | 2010-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA99924C2 (en) | Benzylbenzol derivatives and using thereof | |
| PH12012502395A1 (en) | Crystalline form of benzylbenzene sglt2 inhibitor | |
| WO2010018438A3 (en) | Tetrazole glycosides | |
| WO2007140191A3 (en) | Glucose transport inhibitors and methods of use | |
| WO2010043682A3 (en) | Process for the preparation of compounds useful as inhibitors of sglt | |
| WO2008144346A3 (en) | Crystal structures of sglt2 inhibitors and processes for their preparation | |
| PH12012500698A1 (en) | Process for the preparation of compounds useful as inhibitors of sglt2 | |
| BRPI0816258B8 (en) | process for preparing compounds useful as sglt inhibitors | |
| WO2008012343A3 (en) | Macrolide synthesis process | |
| JO3152B1 (en) | Glycoside derivatives and uses thereof | |
| WO2011048148A3 (en) | Glycoside derivative and uses thereof | |
| WO2008017346A3 (en) | Ascorbic acid derivatives, use thereof for the functionalization of matrices | |
| MY155418A (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | |
| DK2213678T3 (en) | Process for the preparation of dissolved lignin, saccharide feedstock and monosaccharide feedstock as well as dissolved lignin | |
| GEP20146003B (en) | Benzothiazole derivatives as anticancer agents | |
| UA98303C2 (en) | Macrolide synthesis process | |
| WO2007127298A3 (en) | Pucoidans for reducing blood coagulation | |
| WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
| WO2010094837A3 (en) | Sugar product | |
| WO2008041176A3 (en) | Process for the preparation of form i and form ii of ritonavir | |
| WO2010042212A3 (en) | Methods for treating or preventing pain using spicamycin derivatives | |
| WO2010081163A3 (en) | Method for 2-sulfation of glycosides | |
| WO2011009987A3 (en) | Aureolic acid derivatives, the method for preparation thereof and the uses thereof | |
| IL198848A0 (en) | Sodium salt of disaccharide compound, method for producing the same, and use of the same | |
| WO2008068619A3 (en) | Improved method for synthesizing lamotrigine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09786120 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09786120 Country of ref document: EP Kind code of ref document: A2 |